Skip to main content
CARCLO PLC logo

CARCLO PLC — Investor Relations & Filings

Ticker · CAR ISIN · GB0001751915 LEI · 21380078MEM399JPI956 IL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2018-08-29 Major Shareholding Noti…
Country GB United Kingdom
Listing IL CAR

About CARCLO PLC

http://www.carclo-plc.com/

Carclo PLC is a global precision engineering group that designs, industrializes, and manufactures high-reliability solutions and complex components. The company specializes in fine-tolerance, injection-molded plastic parts and multi-component assemblies. Its core competencies encompass the entire production lifecycle, from initial design, engineering, and mold creation to advanced manufacturing processes like precision injection molding and automated assembly. Carclo provides comprehensive supply chain solutions, serving demanding, precision-focused markets including Life Sciences, Aerospace, Optics, and other advanced technology sectors. Key product areas include components for in-vitro diagnostics, drug delivery systems, and advanced optical systems.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly identified by the header 'RNS Number : 1885Z' and contains the standard format for 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership thresholds, which directly corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS (London Stock Exchange news service), the core content is a specific regulatory filing about share ownership changes, making 'MRQ' (Major Shareholding Notification) the most accurate classification over the general 'RNS' fallback.
2018-08-29 English
Form 8.3 - Carclo plc
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code'. This form is used to disclose insider dealings or significant ownership changes related to a takeover offer. This type of disclosure, especially when referencing takeover codes and dealing in securities, falls under insider trading or director/executive transaction reporting. Comparing the definitions, 'Director's Dealing (Code: DIRS)' is the closest fit, as it covers 'Report of personal share transactions by company directors and executives (insider trades)'. Although this specific form (Form 8.3) relates to takeover rules, the core activity being reported is a dealing/position disclosure by an interested party, which aligns best with DIRS among the provided options. It is not a general regulatory filing (RNS) because it is highly specific to insider dealing/takeover rules.
2018-08-08 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS (Regulatory News Service), the specific content is a notification of a change in major holding (crossing a threshold of 6.03% ownership by Axxion S.A.). Therefore, the most specific classification is Major Shareholding Notification (MRQ).
2018-08-07 English
Form 8.3 - Carclo plc
Regulatory Filings Classification · 98% confidence The document is explicitly labeled as 'FORM 8.3' and concerns a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' under 'Rule 8.3 of the Takeover Code'. This type of filing relates to insider transactions or significant ownership changes during a takeover scenario. While it involves director/insider dealings (which might suggest DIRS), the specific context of the Takeover Code (Rule 8.3) and the nature of the disclosure (position disclosure/dealing disclosure related to an offer for 'Carclo plc') strongly aligns with regulatory filings concerning corporate actions, specifically takeovers. Since there is no specific code for Takeover Disclosures, and this is a mandatory regulatory filing disseminated via RNS, it fits best under the general 'Regulatory Filings' (RNS) category, as it is not a standard Director's Dealing report (DIRS) which usually refers to Form 3/4/5 equivalents or general insider trading reports outside of a formal takeover context. However, looking closely at the definitions, 'Director's Dealing' (DIRS) is for 'Report of personal share transactions by company directors and executives (insider trades)'. Form 8.3 is a specific type of insider dealing disclosure mandated by the Takeover Code. Given the options, DIRS is the closest fit for insider transaction reporting, even if the context is a takeover. Let's re-evaluate: DIRS is for insider trades. Form 8.3 is an insider trade disclosure related to a takeover. Since DIRS covers insider trades, and this is a specific insider trade disclosure, I will classify it as DIRS, as it is more specific than the general RNS fallback. The document details ownership and dealings of Axxion S.A. in relation to Carclo plc.
2018-08-07 English
Statement re withdrawal of Consort Medical plc
M&A Activity Classification · 99% confidence The document is very short (2129 characters) and begins with an 'RNS Number' and a date, indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a corporate event (a potential offer withdrawal by Consort Medical plc regarding Carclo plc) and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure strongly suggests a general regulatory announcement that doesn't fit the specific categories like ER, 10-K, or DIV. Since it is a general regulatory news service item, the most appropriate classification is Regulatory Filings (RNS), which serves as the fallback for miscellaneous regulatory announcements.
2018-08-07 English
Consort Medical No Intention to Bid for Carclo plc
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is explicitly marked as 'NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION...' and contains language related to the 'CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")'. The core content is a 'No Intention to Bid Statement' regarding a potential acquisition of Carclo plc. This type of announcement, which is a formal regulatory disclosure concerning M&A activity and compliance with takeover codes, is typically disseminated via regulatory news services. Since it is a specific regulatory announcement that doesn't fit the detailed definitions of 10-K, ER, or IR, and it is clearly a formal regulatory filing disseminated through RNS, the most appropriate classification is RNS (Regulatory Filings) as a general regulatory announcement, although it strongly relates to M&A (TAR). However, given the structure and the explicit mention of RNS and the FCA's role as a Primary Information Provider, RNS is the best fit for the dissemination mechanism of this specific type of formal notice, especially since TAR is defined as M&A Activity announcements, and this is a formal statement of *non-intention* under the Takeover Code, which is a broad regulatory requirement. Given the context of the RNS header and the nature of the announcement (a formal statement under the Takeover Code), RNS is the most accurate general regulatory category.
2018-08-07 English

Browse filings by year

37 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.